AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| TGG | Ann: Daily share buy-back notice - Appendix 3E | 24/04/18 | 0 | 25 | |||
|
|||||||
| TGG | Ann: Weekly NTA | 24/04/18 | 0 | 28 | |||
|
|||||||
| TGG | Ann: Daily share buy-back notice - Appendix 3E | 23/04/18 | 0 | 32 | |||
|
|||||||
| TGG | Ann: Daily share buy-back notice - Appendix 3E | 20/04/18 | 0 | 38 | |||
|
|||||||
| TGG | Ann: Daily share buy-back notice - Appendix 3E | 18/04/18 | 0 | 28 | |||
|
|||||||
| TGG | Ann: Weekly NTA | 17/04/18 | 0 | 45 | |||
|
|||||||
| TGG | Ann: Daily share buy-back notice - Appendix 3E | 17/04/18 | 0 | 24 | |||
|
|||||||
| TGG | Ann: Quarterly Investment Management Report | 16/04/18 | 0 | 47 | |||
|
|||||||
See All Discussions
ASX News